Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Musk's plan to cut $2 trillion in federal spending could clash with his proposal to subsidize a drug costing up to $1,000 a ...

That, according to the firm, make them particularly suitable for users of GLP-1 medications. GLP-1 drugs such as Ozempic and ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

The View” co-host Whoopi Goldberg accused Health and Human Services (HHS) nominee Robert F. Kennedy Jr. of fat shaming ...

Robert F. Kennedy Jr., President-elect Donald Trump’s choice to lead the U.S. Department of Health and Human Services, has ...

Keros Therapeutics, Inc.'s stock plummets 75% due to safety concerns in Phase 2 trial, but partnership with Takeda may offer ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Drugs used to treat diabetes and obesity, or GLP-1 (Glucagon-like peptide-1), will be a significant growth driver for ...